Ahmed与Baerveldt对比研究及Ahmed与Baerveldt研究五年汇总数据分析
该汇总分析纳入两项多中心随机临床试验的514例药物无法控制且小梁切除术后失败或高危青光眼患者,随机接受Ahmed植入物(267例)或Baerveldt植入物(247例)。5年时Baerveldt组累积失败率、再次青光眼手术率及平均眼压均低于Ahmed组,但低眼压所致失败率更高,两组视力结局相似。
要点
- 5年累积失败率Ahmed组49% vs Baerveldt组37%(P = .007)。
- 5年平均眼压Ahmed组15.8 ± 5.2 mm Hg vs Baerveldt组13.2 ± 4.7 mm Hg(P < .001)。
- 低眼压所致失败Ahmed组0.4% vs Baerveldt组4.5%(P = .002)。
核心结论
- Baerveldt组较Ahmed组具有更低的失败率、更低的再次青光眼手术率及更低的平均眼压且用药更少。
- Baerveldt植入物携带更高的低眼压风险。
研究设计与样本
- 两项多中心随机临床试验的汇总分析,共纳入514例18岁及以上、药物无法控制且小梁切除术后失败或高危的青光眼患者。
- 患者随机接受Ahmed植入物(n = 267)或Baerveldt植入物(n = 247)。
- 比较采用6-18 mm Hg(含)眼压目标的累积失败率、再次青光眼手术率、平均眼压、平均青光眼用药及视力。
主要发现
- 术前平均眼压31.5 ± 11.3 mm Hg,平均使用3.3 ± 1.1种青光眼药物。
- 5年时平均眼压Ahmed组15.8 ± 5.2 mm Hg vs Baerveldt组13.2 ± 4.7 mm Hg(P < .001)。
- 5年平均青光眼用药Ahmed组1.9 ± 1.5 vs Baerveldt组1.5 ± 1.4(P = .007)。
- 5年累积失败率Ahmed组49% vs Baerveldt组37%(P = .007)。
- 高眼压是两组最常见的失败原因,再次青光眼手术Ahmed组16% vs Baerveldt组8%(P = .006);低眼压所致失败Ahmed组0.4% vs Baerveldt组4.5%(P = .002);视力结局两组相似(P = .90)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To determine the relative efficacy of the Ahmed-FP7 and Baerveldt BG101-350 implants. DESIGN: Pooled analysis of 2 multicenter, randomized clinical trials. METHODS: A total of 514 patients aged 18 or older with uncontrolled glaucoma that had failed or were at high risk of failing trabeculectomy were randomized to receive an Ahmed implant (n = 267) or Baerveldt implant (n = 247). Cumulative failure rates (using an intraocular pressure [IOP] target of 6-18 mm Hg inclusive), de novo glaucoma surgery rates, mean IOP, mean glaucoma medication use, and visual acuity were compared. RESULTS: Baseline characteristics were similar between groups. Mean preoperative IOP of the study population was 31.5 ± 11.3 mm Hg on an average of 3.3 ± 1.1 glaucoma medications. At 5 years, mean IOP was 15.8 ± 5.2 mm Hg in the Ahmed group and 13.2 ± 4.7 mm Hg in the Baerveldt group (P < .001). Mean glaucoma medication use was 1.9 ± 1.5 in the Ahmed group and 1.5 ± 1.4 in the Baerveldt group (P = .007). The cumulative failure rate at 5 years was 49% in the Ahmed group and 37% in the Baerveldt group (P = .007). High IOP was the most common reason for failure in both groups, and de novo glaucoma surgery was required in 16% of the Ahmed group and 8% of the Baerveldt group (P = .006). Failure owing to hypotony occurred in 0.4% of the Ahmed group and 4.5% of the Baerveldt group (P = .002). Visual outcomes were similar between groups (P = .90). CONCLUSIONS: The Baerveldt group had a lower failure rate, lower rate of de novo glaucoma surgery, and lower mean IOP on fewer medications than the Ahmed group. Baerveldt implantation carried a higher risk of hypotony.
引用
- Christakis PG, Zhang D, Budenz DL, et al. Five-Year Pooled Data Analysis of the Ahmed Baerveldt Comparison Study and the Ahmed Versus Baerveldt Study. Am J Ophthalmol. 2017. PMID: 28104418. doi:10.1016/j.ajo.2017.01.003
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。